ONMDHealthcare · Health Information Services

ONMD Stock Forecast: OneMedNet Corp. Price Predictions for 2026-2027

Last close, 18 Sept 2026

$0.70

+14.57% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 15 of 100 as at 19 Sept 2026 — in the weakest quartile.

Market cap

$41.5M

Ticker Nerd rank

15 / 100

Median analyst target

—

Analysts covering

—

Revenue$292K+88.4% y/y

Operating income−$2.3M

Net income−$2.2M

Free cash flow−$1.9M

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

+7.2%

+16.5%

YTD

−36.4%

−21.3%

From 52W high

−77.7%

From 52W low

+39.7%

$0.50

$3.14

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

ONMD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores OneMedNet Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 19 Sept 2026

15 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Accruals

Volatility

Momentum

Growth

Revisions

Value

Issuance

Quality

Size (84): Smaller than most of the companies we track.

Quality (3): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ONMD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ONMD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ONMD appears on the weeks it earns a place.

Performance

ONMD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 18 Sept 2026, OneMedNet Corp. returned −21.3% against +16.3% for the S&P 500, dividends included.

ONMD vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ONMD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

OneMedNet Corp. (ONMD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 45.0×
Price / sales: 28.5×
Price / book: −11.3×
EV / EBITDA: −4.1×

Growth & margins

Revenue growth (YoY): 88.4%
Earnings growth (YoY): 88.4%
Gross margin: −193.5%
Operating margin: −774.3%
Net margin: −37.0%

Returns & dividend

Return on equity: 94.5%
Return on assets: −342.1%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

OneMedNet Corp. (ONMD) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

OneMedNet Corp. has a market value of $41.5M and an enterprise value of $41.8M.
Revenue in the twelve months to 30 June 2026: $1.5M. The latest quarter grew 88.4% year on year.
Net income over the same four quarters: −$8.5M, a −584.2% net margin.
Free cash flow in the twelve months to 30 June 2026: −$6.9M.
Shares outstanding: 57.7M.
Trailing P/E: 45.0×.
OneMedNet Corp. employs 22 people — $66K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 20 Sept 2026

Data provided by Twelve Data

Peers

ONMD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services

Company	Market cap	TKN rank
ONMDOneMedNet Corp.	$41.5M	15
DRIODarioHealth Corp.	$70.5M	51
BEATHeartBeam, Inc.	$22.7M	17
CCLDCareCloud, Inc.	$92.2M	72
HCATHealth Catalyst, Inc.	$134.7M	50
OPRXOptimizeRx Corp.	$135.3M	81
DHDefinitive Healthcare Corp.	$137.0M	77

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own OneMedNet Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ONMD news & analysis

OneMedNet Reports Record Bookings as Faster Fulfillment Begins

GlobeNewsWire · 18 Sept 2026positive

OneMedNet reported year-to-date bookings of approximately $16.2 million, a 16X increase versus the same period in 2025. The company also noted that faster fulfillment has begun in connection with these record bookings.

Why it matters — A 16X year-over-year jump in bookings signals sharply rising demand for OneMedNet's AI-driven real-world data services, which could be a key indicator for investors tracking the company's growth trajectory.

OneMedNet's iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company

GlobeNewsWire · 31 Aug 2026positive

OneMedNet announced a new agreement to deliver de-identified, full-fidelity clinical Real-World Data to a leading AI-driven drug development company. The company's iRWD Platform enabled cohort feasibility within minutes, data validation within a week, and a signed contract within three weeks of initial contact, and the data is now being delivered to support the customer's development of AI models for drug discovery.

Why it matters — A new commercial agreement with a leading AI-driven drug developer highlights the speed and efficiency of OneMedNet's iRWD platform in converting initial customer contact into signed data-delivery deals, demonstrating commercial traction for its RWD offerings.

OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development

GlobeNewsWire · 28 July 2026positive

OneMedNet announced it has entered into an agreement worth at least $11.5 million to supply its regulatory-grade, multi-modal imaging-centric iRWD platform data for the development and training of a foundational AI model, with data delivery beginning immediately.

Why it matters — This multimillion-dollar agreement validates OneMedNet's regulatory-grade data platform and demonstrates commercial demand for its real-world data in high-value AI model development.

FAQ

Frequently asked questions about ONMD stock

How does Ticker Nerd's model rank ONMD?

As at 19 Sept 2026, OneMedNet Corp. ranks 15 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (84 of 100).

What is the ONMD stock forecast for 2030?

No analyst covering OneMedNet Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ONMD are extrapolating price history, which says nothing about the business.

How has ONMD stock performed over the past year?

OneMedNet Corp. returned -21.3% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does OneMedNet Corp. do?

OneMedNet Corp. Class A Common Stock represents the publicly traded equity of OneMedNet Corp., a healthcare technology company focused on clinical imaging and real-world data services.

What is the latest news on ONMD?

The most recent item we track (GlobeNewsWire, 18 Sept 2026): "OneMedNet Reports Record Bookings as Faster Fulfillment Begins". OneMedNet reported year-to-date bookings of approximately $16.2 million, a 16X increase versus the same period in 2025. The company also noted that faster fulfillment has begun in connection with these record bookings.

Company

About OneMedNet Corp.

OneMedNet Corp. Class A Common Stock represents the publicly traded equity of OneMedNet Corp., a healthcare technology company focused on clinical imaging and real-world data services. OneMedNet provides digital medical image management, exchange, and sharing solutions used across healthcare and life sciences workflows. Its core offerings include iRWD, a platform designed to securely de-identify, curate, search, and share imaging data for medical institutions, research organizations, and industry partners. The company also supports the movement of clinical images and related patient data between providers, hospitals, and research networks. OneMedNet serves customers in the Americas, Europe, and the Middle East, positioning itself within the health information services segment of the market. The stock is associated with a company whose products are centered on imaging data access, regulatory-grade data handling, and clinical research support.

CEO Mr. Aaron Green · 22 employees · United States · https://www.onemednet.com